Subcutaneous rituximab for autoimmune bullous diseases. Riquelme-Mc Loughlin C, Iranzo P. Br J Dermatol 2021;185:870-871.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Riquelme-Mc Loughlin C, Iranzo P. Subcutaneous rituximab for autoimmune bullous diseases. Br J Dermatol 2021;185:870-871.
PMID: 34009646